Human Mesenchymal Stem Cell-Derived Exosomes Promote the Proliferation and Melanogenesis of Primary Melanocytes by Attenuating the H2O2-Related Cytotoxicity in vitro
Yexiao Wang,Zibin He,Bingqin Luo,Hioteng Wong,Liangcai Wu,Hui Zhou
DOI: https://doi.org/10.2147/ccid.s446676
2024-03-18
Clinical Cosmetic and Investigational Dermatology
Abstract:Yexiao Wang, 1, &ast Zibin He, 2, &ast Bingqin Luo, 2 Hioteng Wong, 1 Liangcai Wu, 3 Hui Zhou 1 1 Department of Dermatology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China; 2 MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, People's Republic of China; 3 Department of Dermatology, the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Liangcai Wu; Hui Zhou, Tel +86 13380019222 ; +86 13660389658, Email ; Background: Mesenchymal stem cell-derived exosomes (MSC-Exo) have therapeutic potential. However, the impact of MSC-Exo on the survival and melanogenesis of human primary melanocytes following H 2 O 2 -induced damage has not been clarified. We therefore investigated the effects of MSC-Exo on the H 2 O 2 -affected survival of human primary melanocytes and their proliferation, apoptosis, senescence, and melanogenesis in vitro. Methods: MSC-Exo were prepared from human MSCs by sequential centrifugations and characterized by Transmission Electron Microscopy, Western blot and Nanoparticle Tracking Analysis. Human primary melanocytes were isolated and treated with different concentrations of MSC-Exo, followed by exposing to H 2 O 2 . Furthermore, the impact of pretreatment with MSC-Exo on the proliferation, apoptosis, senescence and melanogenesis of melanocytes were tested by CCK-8, flow cytometry, Western blot, L-Dopa staining, tyrosinase activity and RT-qPCR. Results: Pretreatment with lower doses of MSC-Exo protected human primary melanocytes from the H 2 O 2 -triggered apoptosis, while pretreatment with higher doses of MSC-Exo enhanced the H 2 O 2 -induced melanocyte apoptosis. Compared with the untreated control, pretreatment with a lower dose (1 μg/mL) of MSC-Exo enhanced the proliferation of melanocytes, abrogated the H 2 O 2 -increased p53, p21, IL-1β, IL-6 and IL-8 expression and partially rescued the H 2 O 2 -decreased L-dopa staining reaction, tyrosinase activity, MITF and TRP1 expression in melanocytes. Conclusion: Our findings indicate that treatment with a low dose of MSC-Exo promotes the proliferation and melanogenesis of human primary melanocytes by ameliorating the H 2 O 2 -induced apoptosis and senescence of melanocytes. MSC-Exo may be a promising therapeutic strategy of vitiligo. Keywords: mesenchymal stem cell-derived exosomes, melanocytes, apoptosis, proliferation, senescence Vitiligo is one of the common skin diseases and characterized by the selective destruction of epidermal melanocytes, leading to depigmented patches in the skin or mucous membranes. Vitiligo was first documented as far back as 3500 years ago, 1 and currently affects about 0.5–2% of people in the world. 2,3 Vitiligo affects people of all Fitzpatrick skin types, 4 but it may be more noticeable on darker skin. 5 Vitiligo can involve any part of the body, particularly for the visible areas, such as the face and arms, and even spread to whole body, causing great psychological distress to patients and seriously affecting quality of life of both the patients and their family members. 6,7 In recent years, scientific researchers have made significant progress in understanding the pathogenesis of vitiligo and helped in developing better therapeutic strategies. 1,8 Oxidative stress and autoimmunity-induced melanogenesis impairment and death of melanocyte have been considered to be the two key factors that contribute to the pathogenesis of vitiligo. 2 It is currently believed that oxidative stress plays a pivotal role in initiating the autoimmune response associated with vitiligo 9 and IFN-γ-CXCL9/CXCL10-CXCR3 Axis leads to melanocyte destruction in vitiligo. 10–12 Furthermore, premature senescence of melanocytes is also crucial for the development and progression of vitiligo. 13,14 Although a variety of treatments are available, including phototherapy, 15 topical medications, 2 systemic drugs, 16 surgery 17 and targeted therapies, 8 the efficacy of these treatments still remains unsatisfactory. 2,18 Nearly 40% of vitiligo patients relapse, due to lesional CD8 + resident memory T cells (T RM ), 19 within one year after discontinuation of treatme -Abstract Truncated-
dermatology